Form 4 for ANIX Anixa Biosciences Inc
Accepted 2024-07-29 00:00:00 ET · period of report 2024-07-25 · accession 0001493152-24-029354 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-07-29 | 2024-07-25+ | ANIX | Titterton Lewis H jr | Dir | P - Purchase | $3.01 | +8,496 | 861.4K | +1.0% | +$25.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-07-26 | P | A | 7,700 | $3.03 | 869,108 | D | — | — | |
| 2 | Common | Common Stock | 2024-07-25 | P | A | 796 | $2.81 | 861,408 | D | — | — |